Home » Topics » Disease categories and therapies » Infection

Infection
RSS

New treatment options improve outlook for patients with viral skin infections

Dec. 3, 1996

Lidak reacquires certain rights to Lidakol from BMS

Dec. 2, 1996

Ivermectin approved for use in humans

Dec. 2, 1996

Merck & Co. describes lipid A biosynthesis inhibitor with antibacterial activity

Dec. 2, 1996

Frog peptides with antimicrobial activity available for licensing

Dec. 2, 1996

Antimicrobial peptide combinations available for licensing

Dec. 2, 1996

Takeda describes antiprotozoal agents

Nov. 29, 1996

Antimicrobial ranalexin peptides available for licensing

Nov. 28, 1996

New antibacterial agents under study at Bayer

Nov. 28, 1996

FDA approves Amphotec

Nov. 27, 1996

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
RX-10616 improves radiotherapy efficacy in HNSCC
BioWorld Science
Head and neck squamous cell carcinoma (HNSCC) accounts for high number of new diagnoses each year. Current management is based on surgery followed by radiotherapy...
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...